Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
As the majority of patients with type 2 diabetes are overweight or obese this offers a potential advantage over older, established therapies, and DPP-4 inhibitors are being used in clinical practice as second-line therapy in addition to metformin in overweight and obese patients who fail to reach glycemic targets with metformin monotherapy
"Important safeguards include identifying which patients qualify for this type of care, professional medical oversight by qualified providers and a structured follow-up plan to ensure continuity of care, avoiding one-time, isolated prescriptions that leaves patients to their own devices." The Case for Virtual Care "Telehealth is a great way to improve access to evidence-based obesity treatment," says Dr
Water retention, hormonal cycles, and even how recently you ate before stepping on the scale can shift the number day to day
Bickel is a principal of HealthSim, LLC
US$ 29.86
US$ 29.79
US$ 26.56
US$ 24.30
US$ 25.29
US$ 20.05
US$ 26.81
US$ 21.45
